ABOUT GlobeImmune
NEWSROOM
CAREERS
CONTACT US
INVESTORS
Platform
Product Pipeline
Tarmogen Platform
Cancer
Oncology Pipeline
GI-4000 / Mutated Ras
GI-6207 / CEA
GI-6301 / Brachyury
Infectious Disease
Infectious Disease Pipeline
GS-4774 / HBV
GlobeImmune
|
SEC Filings
|
4 – 2016-03-02
4 – 2016-03-02
Print
January 1, 1970
Statement of changes in beneficial ownership of securities